A new AR therapy (MP29-02*): all of ARIA in one puff

Ejemplares similares

• MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
  por: Scadding, Glenis, et al.
  Publicado: (2015)
• A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
  por: Hellings, Peter, et al.
  Publicado: (2015)
• Real-life effectiveness of a new allergic rhinitis therapy (MP29-02*) in Sweden
  por: Stjärne, Pär, et al.
  Publicado: (2015)
• The effect of MP29-02* is mediated via bitter taste receptors (TAS2R)
  por: Ekstedt, Sandra, et al.
  Publicado: (2015)
• A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
  por: Hellings, Peter, et al.
  Publicado: (2013)